UNIVEC Receives FDA 510(k) Clearance for its New Smaller Immunization Safety Syringe

Farmingdale-based Univec, Inc., (OTCBB:UNVC - news) a leading manufacturer of patented auto-disable and safety syringes, and other medical devices, today announced FDA 510(k) clearance for its new safety syringe designed for 0.5cc immunizations such as Flu and Pneumonia.

FARMINGDALE, N.Y.--(PRWeb)-February 27, 2002 Farmingdale-based Univec, Inc., (OTCBB:UNVC - news) a leading manufacturer of patented auto-disable and safety syringes, and other medical devices, today announced FDA 510(k) clearance for its new safety syringe designed for 0.5cc immunizations such as Flu and Pneumonia. The 1cc Univec Immunization Safety Syringes are available with 23-gauge, l-inch needles. The syringes are faster and easier to fill and take up less space than other immunization syringes. The Univec patented sliding sheath mechanism complies with OSHA regulations by engaging with only one hand to effectively reduce the risk of accidental needle sticks.

According to Dr. David L. Dalton, Univecs President and CEO, the Univec Immunization Safety Syringe was specifically designed to facilitate delivery of vaccines. We believe all vaccine delivery in the U.S. should comply with the U.S. Needle Stick Law and OSHA requirements to protect patients and healthcare workers, and the New Univec Immunization Safety Syringe does that."
Leading health experts have documented that traditional disposable syringes are the leading cause for the spread of blood-borne pathogens such as HIV/AIDS and Hepatitis. The World Health Organization and UNICEF have now banned use of traditional disposable syringes for all vaccine programs.

About Univec
Founded in 1992, Univec is considered one of the leading innovators in the design and production of auto-disable and safety syringes. The Company has production facilities in Portugal, South Korea, China, Belgium and the U.S., and has licensed its technology to Terumo of Belgium; a subsidiary of Terumo Japan, the leading producer of syringes outside the U.S. Univec distributes its products in 80 countries.

Forward Looking Statements
This document contains forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univecs business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univecs reports to the Securities and Exchange Commission, which include Univecs Annual Report on Form 10-K. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univecs reports filed with the SEC.

Contact:
G. Edward Kalbaugh
Allegent Growth Strategies International
516-364-7034 or e-mail gekalbaugh@allegentgsi.com